KIMS Partners with Renova to Strengthen Cancer Care

Mumbai, April 24: Krishna Institute of Medical Sciences has partnered with Renova Healthcare Services to enhance its oncology capabilities, focusing on improving treatment quality, the company said in an exchange filing. 

The collaboration is structured as a non-commercial arrangement, meaning it does not carry a direct revenue component. Instead, the emphasis is on sharing expertise and refining clinical practices. 

As part of the tie-up, Renova will bring in experience across oncology protocols, research-based treatment approaches and academic guidance. KIMS plans to use this to standardise cancer care across its hospitals and improve patient outcomes over time. 

KIMS share price edged lower following the announcement. At 11:55 a.m. IST, the stock was trading at ₹646.85, down 1.24% from its previous close of ₹654.95. It moved in a range of ₹645.45 to ₹657.00 during the session. 

The muted market reaction reflects a wait-and-watch approach, as such collaborations typically take time to translate into visible financial performance. 

Oncology remains a critical and fast-evolving area for hospital operators, requiring specialised expertise and consistent upgrades in treatment standards. The company said the partnership is aimed at building long-term clinical depth in this segment rather than driving short-term growth. 

Source: 

• https://www.nseindia.com/get-quote/equity/KIMS/Krishna-Institute-of-Medical-Sciences-Limited 
• https://nsearchives.nseindia.com/corporate/KIMS_23042026154743_Disclosure.pdf